Shi Q, Sobrero AF, Shields AF, et al. Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration. J Clin Oncol 35, 2017 (suppl; abstr LBA1).
Proefschrift: verbeterpunten voor vaccinatie en preventie van HPV en hiv
dec 2021 | Gynaecologische oncologie, HIV, Virale infecties